Cheng, Shih-Lung;
Lin, Ching-Hsiung;
Chu, Kuo-An;
Lin, sheng-Hao;
Lin, Horng-Chyuan;
Ko, Hsin-kuo;
che, Yung-Che;
Chen, Chia-Hung;
Sheu, Chau-Chyun;
Huang, Wei-Chang;
Lin, Meng-Chih.
Chronic obstructive pulmonary disease (COPD) has significant contributions to morbidity and mortality world-wide. Early symptoms of COPD are not readily distinguishable, resulting in a low rate of diagnosis and intervention. Different guidelines and recommendatations for the diagnosis and treatment of CO...
Miravitlles, Marc;
Calle, Myriam;
Molina, Jesús;
Almagro, Pere;
Gómez, José-Tomás;
Trigueros, Juan Antonio;
Cosío, Borja G;
Casanova, Ciro;
López-Camposb, José Luis;
Riescob, Juan Antonio;
Simonetl, Pere;
Rigau, David;
Soriano, Joan B;
Ancochea, Julio;
Soler-Cataluña, Juan José.
The Spanish COPD Guidelines (GesEPOC) were first published in 2012, and since then have undergone a series of updates incorporating new evidence on the diagnosis and treatment of COPD. GesEPOC was drawn up in partnership with scientific societies involved in the treatment of COPD and the Spanish Patients...
O termo "doença pulmonar obstrutiva crônica, ou DPOC" (eng. doença pulmonar obstrutiva crônica ou DPOC) foi introduzido pela primeira vez em 1962 para denotar “obstrução crônica das vias aéreas de etiologia obscura” (1). Além da DPOC, circulavam em sentido semelhante os diagnósticos “doe...
Generar recomendaciones basadas en la mejor evidencia disponible acerca del manejo
clínico de personas con Enfermedad Pulmonar Obstructiva Crónica (EPOC). Con especial enfoque en el apoyo a los equipos de salud en la toma de decisiones respecto al tratamiento y derivación de las personas con
EPOC....
This guideline covers diagnosing and managing chronic obstructive pulmonary disease or COPD
(which includes emphysema and chronic bronchitis) in people aged 16 and older. It aims to help
people with COPD to receive a diagnosis earlier so that they can benefit from treatments to reduce
symptoms, improve q...
This guideline sets out an antimicrobial prescribing strategy for acute exacerbations of chronic
obstructive pulmonary disease (COPD). It aims to optimise antibiotic use and reduce antibiotic
resistance....
This guideline sets out an antimicrobial prescribing strategy for acute exacerbations of chronic obstructive pulmonary disease (COPD). It aims to optimise antibiotic use and reduce antibiotic resistance. This guideline includes recommendations on: treatment; reassessment; referral and seeking specialist ...
Wedzicha, JA;
Calverley, PMA;
Albert, RK;
Anzueto, A;
Criner, GJ;
Hurst, JR;
Miravitlles, M;
Papi, A;
Rabe, KF;
Rigau, D;
Sliwinski, P;
Tonia, T;
Vestbo, J;
Wilson, KC;
Krishnan, JA.
This document provides clinical recommendations for the prevention of chronic obstructive pulmonary disease (COPD) exacerbations. It represents a collaborative effort between the European Respiratory Society and the American Thoracic Society.Comprehensive evidence syntheses were performed to summarise al...
Agonistes des récepteurs béta-2 adrénergiques/usage thérapeutique,
Aminopyridines/usage thérapeutique,
Benzamides/usage thérapeutique,
Cyclopropanes/usage thérapeutique,
Fluoroquinolones/usage thérapeutique,
Macrolides/usage thérapeutique,
Antagonistes muscariniques/usage thérapeutique,
Inhibiteurs de la phosphodiestérase-4/usage thérapeutique,
Évolution de la maladie,
Broncho-pneumopathie chronique obstructive,
Broncho-pneumopathie chronique obstructive/traitement médicamenteux,
Broncho-pneumopathie chronique obstructive/physiopathologie,
Prévention secondaire/normes,
Agonistes des récepteurs béta-2 adrénergiques,
Aminopyridines,
Benzamides,
Cyclopropanes,
Fluoroquinolones,
Macrolides,
Antagonistes muscariniques,
Inhibiteurs de la phosphodiestérase-4
Miravitlles, M;
Soler-Cataluña, J. J;
Calle, M;
Molina, J;
Almagro, P;
Quintano, J. A;
Trigueros, J. A;
Cosío, B. G;
Casanova, C;
Antonio Riesco, J;
Simonet, P;
Rigau, D;
Soriano, J. B;
Ancochea, J.
La enfermedad pulmonar obstructiva crónica (EPOC) presenta una gran heterogeneidad clínica, por lo que su tratamiento se debe individualizar según el nivel de riesgo y el fenotipo. La Guía española de la EPOC (GesEPOC) estableció por primera vez en 2012 unas pautas de tratamiento farmacológico bas...
Para realizar este manual se generó un proceso técnico basado en el análisis de la mejor evidencia disponible en el tema, y uno participativo en el que múltiples grupos de expertos y organizaciones interesadas hicieron su aporte en la generación del manual. Dirigido a población colombiana y reside...
